BostonGene

BostonGene is a developer of an AI foundation model for tumor and immune biology that transforms immuno-oncology drug development through advanced biomarker discovery, real-time monitoring, and precision patient selection. The company's omnimodal platform combines high-resolution immune profiling with circulating-free RNA (cfRNA)-based tumor detection to enable accurate prediction of therapeutic response and resistance.